We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Clear all

Refine your search

1 results found

Article

Reed Smith LLP | USA | 7 Jan 2009

Ovation Pharmaceutical, Inc

On Dec. 16, 2008, the FTC filed a complaint against Ovation Pharmaceuticals, Inc. in the U.S. District Court for the District of Minnesota, alleging that the Illinois-based drug manufacturer illegally charged monopoly prices for its drug that is used to treat a life-threatening heart condition in premature infants, after purchasing the only similar medicine from a competitor in 2006.

Previous page 1 Next page